Network-Driven Plasma Proteomics Expose Molecular Changes in the Alzheimer's Brain
2016
Background
Biological pathways that significantly contribute to sporadic Alzheimer’s disease are largely unknown and cannot be observed directly. Cognitive symptoms appear only decades after the molecular disease onset, further complicating analyses. As a consequence, molecular research is often restricted to late-stage post-mortem studies of brain tissue. However, the disease process is expected to trigger numerous cellular signaling pathways and modulate the local and systemic environment, and resulting changes in secreted signaling molecules carry information about otherwise inaccessible pathological processes.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
89
References
24
Citations
NaN
KQI